Cassali GD - Search Results

1

Preclinical evaluation of L-fucoside from lapachol-loaded nanoemulsion as a strategy to breast cancer treatment.

Miranda SEM, de Alcantara Lemos J, Ottoni FM, Cassali GD, Townsend DM, de Aguiar Ferreira C, Alves RJ, Ferreira LAM, de Barros ALB. Miranda SEM, et al. Among authors: cassali gd. Biomed Pharmacother. 2024 Jan;170:116054. doi: 10.1016/j.biopha.2023.116054. Epub 2023 Dec 26. Biomed Pharmacother. 2024. PMID: 38150876 Free article.

2

Antitumoral activity and toxicity of PEG-coated and PEG-folate-coated pH-sensitive liposomes containing ¹⁵⁹Gd-DTPA-BMA in Ehrlich tumor bearing mice.

Soares DC, Cardoso VN, de Barros AL, de Souza CM, Cassali GD, de Oliveira MC, Ramaldes GA. Soares DC, et al. Among authors: cassali gd. Eur J Pharm Sci. 2012 Jan 23;45(1-2):58-64. doi: 10.1016/j.ejps.2011.10.018. Epub 2011 Nov 4. Eur J Pharm Sci. 2012. PMID: 22079137

3

Long-circulating, pH-sensitive liposomes versus long-circulating, non-pH-sensitive liposomes as a delivery system for tumor identification.

de Barros AL, Mota Ld, Soares DC, de Souza CM, Cassali GD, Oliveira MC, Cardoso VN. de Barros AL, et al. Among authors: cassali gd. J Biomed Nanotechnol. 2013 Sep;9(9):1636-43. doi: 10.1166/jbn.2013.1649. J Biomed Nanotechnol. 2013. PMID: 23980511

4

Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model.

de Souza CM, Araújo e Silva AC, de Jesus Ferraciolli C, Moreira GV, Campos LC, dos Reis DC, Lopes MT, Ferreira MA, Andrade SP, Cassali GD. de Souza CM, et al. Among authors: cassali gd. Biomed Pharmacother. 2014 Feb;68(1):51-7. doi: 10.1016/j.biopha.2013.08.004. Epub 2013 Aug 26. Biomed Pharmacother. 2014. PMID: 24054045

5

Synthesis of nitroaromatic compounds as potential anticancer agents.

Lopes MS, de Andrade Sena CF, Silva BL, de Souza CM, Ramos JP, Cassali GD, de Souza-Fagundes EM, Alves RJ, de Oliveira MC, de Oliveira RB. Lopes MS, et al. Among authors: cassali gd. Anticancer Agents Med Chem. 2015;15(2):206-16. doi: 10.2174/1871520614666141114201749. Anticancer Agents Med Chem. 2015. PMID: 25403167

6

pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study.

Silva JO, Fernandes RS, Lopes SC, Cardoso VN, Leite EA, Cassali GD, Marzola MC, Rubello D, Oliveira MC, de Barros AL. Silva JO, et al. Among authors: cassali gd. Mol Imaging Biol. 2016 Dec;18(6):898-904. doi: 10.1007/s11307-016-0964-7. Mol Imaging Biol. 2016. PMID: 27172938

7

HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland.

Damasceno KA, Ferreira E, Estrela-Lima A, Gamba Cde O, Miranda FF, Alves MR, Rocha RM, de Barros AL, Cassali GD. Damasceno KA, et al. Among authors: cassali gd. PLoS One. 2016 Aug 4;11(8):e0160419. doi: 10.1371/journal.pone.0160419. eCollection 2016. PLoS One. 2016. PMID: 27490467 Free PMC article.

8

Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.

Fernandes RS, Silva JO, Monteiro LOF, Leite EA, Cassali GD, Rubello D, Cardoso VN, Ferreira LAM, Oliveira MC, de Barros ALB. Fernandes RS, et al. Among authors: cassali gd. Biomed Pharmacother. 2016 Dec;84:252-257. doi: 10.1016/j.biopha.2016.09.032. Epub 2016 Sep 21. Biomed Pharmacother. 2016. PMID: 27664949

9

Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice.

Dos Santos Ferreira D, Jesus de Oliveira Pinto BL, Kumar V, Cardoso VN, Fernandes SO, Souza CM, Cassali GD, Moore A, Sosnovik DE, Farrar CT, Leite EA, Alves RJ, de Oliveira MC, Guimarães AR, Caravan P. Dos Santos Ferreira D, et al. Among authors: cassali gd. Nanomedicine. 2017 Jul;13(5):1693-1701. doi: 10.1016/j.nano.2017.03.005. Epub 2017 Mar 23. Nanomedicine. 2017. PMID: 28343016 Free PMC article.

10

Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model.

Marostica LL, de Barros ALB, Oliveira J, Salgado BS, Cassali GD, Leite EA, Cardoso VN, Lang KL, Caro MSB, Durán FJ, Schenkel EP, de Oliveira MC, Simões CMO. Marostica LL, et al. Among authors: cassali gd. Toxicol Appl Pharmacol. 2017 Aug 15;329:272-281. doi: 10.1016/j.taap.2017.06.007. Epub 2017 Jun 10. Toxicol Appl Pharmacol. 2017. PMID: 28610991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page